GlassScriptPhysician profile
Jason D Roth
NPI 1508816992
$2,384.55
in general payments reported to CMS, 2019-2025
11 companies · $665 in 2025
The $665 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $141 · 2023: $194 · 2024: $185 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $1,231.38 | 2021-2023 | |
| Bioventus LLC | $216.60 | 2022-2025 | Durolane |
| Edwards Lifesciences Corporation | $190.41 | 2025 | Sapien 3 Ultra Resilia |
| Silk Road Medical, INC. | $149.27 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Zimmer Biomet Holdings, INC. | $143.04 | 2023 | Accufill |
| Smith+Nephew, INC. | $138.87 | 2025 | Pico |
| Novartis Pharmaceuticals Corporation | $123.75 | 2025 | |
| Si-Bone, INC. | $100.55 | 2025 | |
| Vericel Corporation | $37.96 | 2022-2023 | Maci |
| Medacta USA, INC. | $35.42 | 2024 | |
| Mf Med | $17.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.